Paper665772
Glomerular permselectivity: barrier function based on discrimination of molecular size and charge.
Brenner BM and 2 others. Am J Physiol, 1978. Cited by 194 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Papers, record 665772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/665772
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glomerular permselectivity: barrier function based on discrimination of molecular size and charge.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Glomerulus | Major topic |
| Animals | |
| Dextrans | |
| Disease Models, Animal | |
| Glomerular Filtration Rate | |
| Humans | |
| Ions | |
| Kidney Diseases | |
| Molecular Weight | |
| Nephrotic Syndrome | |
| Permeability | |
| Proteinuria | |
| Puromycin | |
| Rats |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 194 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,390,947 | A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/41390947 | PubMed |
| 39,491,501 | Targeted therapeutic strategies for the kidney. | Expert Opin Ther Targets | 2024 | https://conductscience.org/library/papers/39491501 | PubMed |
| 38,805,267 | Charge barriers in the kidney elimination of engineered nanoparticles. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38805267 | PubMed |
| 38,409,369 | Physiological principles underlying the kidney targeting of renal nanomedicines. | Nat Rev Nephrol | 2024 | https://conductscience.org/library/papers/38409369 | PubMed |
| 37,677,155 | Versatile Biodegradable Poly(acrylic acid)-Based Hydrogels Infiltrated in Porous Titanium Implants to Improve the Biofunctional Performance. | Biomacromolecules | 2023 | https://conductscience.org/library/papers/37677155 | PubMed |
| 36,882,605 | In vivo Assessment of the Impact of Molecular Weight on Constructs of 68Ga-DOTA-Manocept in a Syngeneic Mouse Tumor Model. | Mol Imaging Biol | 2023 | https://conductscience.org/library/papers/36882605 | PubMed |
| 36,810,461 | Modeling Podocyte Ontogeny and Podocytopathies with the Zebrafish. | J Dev Biol | 2023 | https://conductscience.org/library/papers/36810461 | PubMed |
| 36,376,202 | Determinants of target absorbed dose in radionuclide therapy. | Z Med Phys | 2023 | https://conductscience.org/library/papers/36376202 | PubMed |
| 35,866,051 | Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis. | Int J Nephrol | 2022 | https://conductscience.org/library/papers/35866051 | PubMed |
| 35,607,958 | Biochemical mechanism underlying the pathogenesis of diabetic retinopathy and other diabetic complications in humans: the methanol-formaldehyde-formic acid hypothesis. | Acta Biochim Biophys Sin (Shanghai) | 2022 | https://conductscience.org/library/papers/35607958 | PubMed |
| 34,987,782 | The scientific principles and technological determinants of haemodialysis membranes. | Clin Kidney J | 2021 | https://conductscience.org/library/papers/34987782 | PubMed |
| 34,772,234 | Carbon Nanotubes: Current Perspectives on Diverse Applications in Targeted Drug Delivery and Therapies. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34772234 | PubMed |
| 32,871,201 | Recent trends in protein and peptide-based biomaterials for advanced drug delivery. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32871201 | PubMed |
| 32,409,263 | Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer. | Nucl Med Biol | 2021 | https://conductscience.org/library/papers/32409263 | PubMed |
| 32,075,165 | Photochemical Internalization for Intracellular Drug Delivery. From Basic Mechanisms to Clinical Research. | J Clin Med | 2020 | https://conductscience.org/library/papers/32075165 | PubMed |
| 31,720,858 | Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants. | Metabolomics | 2019 | https://conductscience.org/library/papers/31720858 | PubMed |
| 31,210,755 | Bioimpedance Resistance Indices and Cell Membrane Capacitance Used to Assess Disease Status and Cell Membrane Integrity in Children with Nephrotic Syndrome. | ScientificWorldJournal | 2019 | https://conductscience.org/library/papers/31210755 | PubMed |
| 30,855,196 | Proteomic profiling of urine: implications for lupus nephritis. | Expert Rev Proteomics | 2019 | https://conductscience.org/library/papers/30855196 | PubMed |
| 29,889,556 | Urinary Alpha-1-Acid Glycoprotein Is a Sensitive Marker of Glomerular Protein Leakage at Altitude. | High Alt Med Biol | 2018 | https://conductscience.org/library/papers/29889556 | PubMed |
| 29,805,343 | Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy. | EXCLI J | 2018 | https://conductscience.org/library/papers/29805343 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/665772
GET https://conductscience.org/api/papers/v1/665772/cited_by?page=2